在COVID之后的呼吸道和其他感染
Andrea J Allen1, Nhat Nguyen1, Vitaly Lorman1
1Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Pediatrics
|August 4, 2025
概括
患有SARS-CoV-2感染的儿童没有更高的风险随后的呼吸道同胞病毒 (RSV) 或其他感染. 这项研究比较了SARS-CoV-2感染儿童的感染风险与流感和其他呼吸系统疾病.
科学领域:
- 儿童传染病 儿童传染病
- 病毒学 病毒学
- 流行病学 流行病学
背景情况:
- 2022年呼吸道同胞性病毒 (RSV) 病例的激增促使对潜在的促成因素进行调查,包括在SARS-CoV-2感染后免疫抑制.
- 了解SARS-CoV-2对儿童随后感染风险的影响对于公共卫生战略至关重要.
研究的目的:
- 为了比较随后的呼吸道同胞性病毒 (RSV) 和其他感染的风险,在有或没有之前的SARS-CoV-2感染的儿童中.
- 评估SARS-CoV-2感染与儿童群体其他呼吸道疾病发生率之间的关联.
主要方法:
- 一项回顾性队列研究利用了来自美国27个卫生系统的电子健康记录.
- 感染SARS-CoV-2的5岁以下儿童与患有流感或其他呼吸道感染的儿童进行了比较.
- 治疗逆概率加权和加权后勤回归被应用来分析15至180天的结果.
主要成果:
- 与患有流感 (aOR 0.73) 或其他呼吸道感染 (aOR 0.78) 的儿童相比,患有SARS-CoV-2感染的儿童随后出现RSV的几率较低.
- 与流感组相比,SARS-CoV-2组的任何呼吸道感染和任何感染的几率也较低.
- 在SARS-CoV-2感染后6个月内没有观察到RSV或其他感染的风险增加.
结论:
- 儿童的SARS-CoV-2感染与随后的RSV,呼吸道或6个月内任何类型感染的风险增加无关.
- 研究结果表明,SARS-CoV-2感染不会在短期内增加对其他常见儿童感染的易感性.
- 导致RSV风险增加的SARS-CoV-2诱导免疫抑制假设在本研究中没有得到支持.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.2K
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
5.0K
相关概念视频
Pneumonia I: Introduction
330
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
330
Other Pulmonary Disorders
911
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
911
Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
Common Respiratory Disorders
925
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
925
Pneumonia II: Pathophysiology
559
The pathophysiology of pneumonia involves the following steps:
559
Acute Respiratory Failure-V
208
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
208
